PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-02-02

Date Title Company
02-Feb-2023 PharmaCyte Biotech to Implement Second $10-Million Share Repurchase Plan Businesswire
02-Feb-2023 OM1 Launches Analytic Reports Uncovering Causes of Medication Discontinuation in Immunology Patients Businesswire
02-Feb-2023 Vistagen Announces Closing of Pherin Pharmaceuticals Acquisition Businesswire
02-Feb-2023 Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application Businesswire
02-Feb-2023 Coya Therapeutics, Inc. to Present Proof of Concept Clinical Data at Multiple Scientific Conferences Throughout 2023 Businesswire
02-Feb-2023 Life Science Connect Drives 5x Revenue Growth with ON24 Businesswire
02-Feb-2023 RefleXion Receives FDA Clearance for SCINTIX Biology-Guided Radiotherapy; Cutting-edge Treatment Applicable for Early and Late-stage Cancers Businesswire
02-Feb-2023 Former FDA Senior Officials Join Greenleaf Health: Sandra Kweder, M.D., former Deputy Director of FDA’s Office of New Drugs & Donald D. Ashley, J.D., former Director of CDER’s Office of Compliance Businesswire
02-Feb-2023 Athersys to Host Business Update Conference Call on February 14th Businesswire
02-Feb-2023 Oligomerix Announces First-in-Human Dosing of Tau Self-Association Inhibitor OLX-07010 Businesswire
02-Feb-2023 Fluence Selected as LED Technology Partner by Major Cannabis Cultivators in Growing Portuguese Market Businesswire
02-Feb-2023 OptiBiotix to showcase its progressive microbiome research at Probiota 2023 OptiBiotix Health Plc
02-Feb-2023 CI&T and Box1824 present trends study for the next five years Businesswire
02-Feb-2023 Flare Therapeutics to Present at Guggenheim Healthcare Talks 2023 Oncology Day Businesswire
02-Feb-2023 Exscientia Announces First-in-Human Study for Bristol Myers Squibb In-Licensed PKC Theta Inhibitor, EXS4318 Businesswire
02-Feb-2023 PLAYSTUDIOS Announces Games Industry Veteran Mickey Sonnino as Global COO Businesswire
02-Feb-2023 Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera Businesswire
02-Feb-2023 Thermo Fisher Scientific to Power All Current U.S. Sites With 100 Percent Renewable Electricity Businesswire
02-Feb-2023 Akanda Books €1.8M of Revenue in Q4 2022 As German Sales Start Businesswire
02-Feb-2023 ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder Businesswire